Søren Knud Carlsen
Directeur/Bestuurslid bij Tekniikan Akatemia -säätiö sr
Oorsprong van het eerstegraads netwerk van Søren Knud Carlsen
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 27 | |
| Extinct | Food: Specialty/Candy | 18 | |
Tekniikan Akatemia -säätiö sr
 Tekniikan Akatemia -säätiö sr Investment Trusts/Mutual FundsMiscellaneous Tekniikan Akatemia -säätiö sr, also known as Technology Academy Finland (TAF), is based in Helsinki, Finland. The CEOs of the Finnish company are Mikko Salaspuro and Ainomaija Susanna Haarla. TAF awards the €1 million Millennium Technology Prize and organizes associated events and initiatives. The private company provides an international meeting ground for corporate life, academia, and policymakers, and promotes Finland's position in the community. The Millennium Technology Prize is the world's most prestigious award for breakthrough innovations that improve the quality of people's lives.
16
| Private Company | Investment Trusts/Mutual Funds | 16 |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark.
12
| Operating Division | Investment Managers | 12 |
Bioneer A/S
 Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Biosyntia ApS
 Biosyntia ApS BiotechnologyHealth Technology Biosyntia ApS provides services in synthetic biology and metabolic engineering fields. It offers biocatalysts for fermentation of fine chemicals. The company was founded by Andreas Hougaard Laustsen, Morten Otto Alexander Sommer, and Hans Jasper Genee in 2012 and is headquartered in Copenhagen, Denmark.
7
| Holding Company | Biotechnology | 7 |
Novo Seeds
 Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark.
5
| Operating Division | Investment Managers | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Søren Knud Carlsen via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Chairman Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Investment Officer Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO Chief Investment Officer Chief Executive Officer | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member | |
| Technical University of Denmark | College/University | Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Doctorate Degree | |
| Copenhagen Business School | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
Chr. Hansen A/S
 Chr. Hansen A/S Pharmaceuticals: OtherHealth Technology Chr. Hansen A/S engages in bioscience research that develops natural solutions for the food, nutritional, pharmaceutical and agricultural industries. It also develops and produces cultures, enzymes, probiotics and natural colors for a rich variety of foods, confectionery, beverages, dietary supplements and even animal feed. The company was founded by Christian D. A Hansen in 1874 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Other | Director/Board Member Corporate Officer/Principal Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member | |
Elinkeinoelämän Keskusliitto ry
 Elinkeinoelämän Keskusliitto ry Miscellaneous Commercial ServicesCommercial Services Elinkeinoelämän Keskusliitto ry is a business organization based in Helsinki, Finland. and has subsidiaries in Finland. The Finnish company operates as a business organization. The CEO of the private company is Jyri Jukka Häkämies. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| University of Helsinki | College/University | Doctorate Degree Graduate Degree Graduate Degree Corporate Officer/Principal | |
Teknologiateollisuus ry
 Teknologiateollisuus ry Miscellaneous Commercial ServicesCommercial Services Teknologiateollisuus ry operates as a lobbying organization for technology industry companies. It promotes the competitiveness of the Finnish technology industries and communicates about the diversity and significance of the industries. The company was founded on September 13, 1978 and is headquartered in Helsinki, Finland. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Director/Board Member | |
East Office of Finnish Industries Oy
 East Office of Finnish Industries Oy Miscellaneous Commercial ServicesCommercial Services East Office of Finnish Industries Oy operates as a business association. The private company is based in Helsinki, Finland. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Director/Board Member Chairman | |
| University of Aarhus | College/University | Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
| Aalto University | College/University | Corporate Officer/Principal Director/Board Member Graduate Degree Corporate Officer/Principal | |
Affinicon ApS
 Affinicon ApS Pharmaceuticals: MajorHealth Technology Affinicon ApS operates as a biotechnology company. It develops combinatory drugs for treatment of diseases such as inflammation, infections, and certain forms of cancer. The firm exploits a novel platform technology for targeted delivery of known drugs to macrophages. The company was founded by Niels Jonas Heilskov Graversen on July 4, 2013 and is headquartered in Aarhus, Denmark. | Pharmaceuticals: Major | Chairman Chairman Director/Board Member | |
Avilex Pharma ApS
 Avilex Pharma ApS Pharmaceuticals: MajorHealth Technology Avilex Pharma ApS develops and produces drugs to treat brain damage with the uses of dimeric ligands. It also develops novel inhibitors to target a range of unmet medical needs. The firm uses dimeric ligands that targets intracellular with unprecedented potency. The company was founded by Kristian Strømgaard and Anders Bach on December 27, 2012 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman Chairman Director/Board Member | |
| BIOHIT OYJ | Medical Specialties | Director/Board Member Founder Director/Board Member | |
| BIOPORTO A/S | Medical Specialties | Director/Board Member Chief Operating Officer Chief Operating Officer | |
Pcovery ApS
 Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
EpiTherapeutics ApS
 EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| KONECRANES OYJ | Trucks/Construction/Farm Machinery | Chief Executive Officer Chief Executive Officer Sales & Marketing | |
| INOZYME PHARMA, INC. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
| Yale University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Human Resources Officer Chief Tech/Sci/R&D Officer | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Chief Investment Officer Corporate Officer/Principal Corporate Officer/Principal | |
| GALECTO, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| NOKIA OYJ | Telecommunications Equipment | Chief Tech/Sci/R&D Officer Chief Executive Officer Public Communications Contact | |
Thesan Pharmaceuticals, Inc.
 Thesan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thesan Pharmaceuticals, Inc. provides novel therapeutics for disorders of the skin. The company focuses on the discovery and development of new chemical entities that provide improved treatment options to patients. Thesan Pharmaceuticals was founded in 2011 by Edward P. Monaghan and is headquartered in Carlsbad, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Lux Biosciences, Inc.
 Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| IVERIC BIO, INC. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
| University of Pennsylvania Medical Center | College/University | Doctorate Degree Doctorate Degree | |
Epsilon-3 Bio Ltd
 Epsilon-3 Bio Ltd Pharmaceuticals: OtherHealth Technology Epsilon-3 Bio Ltd. develops compounds targeting the removal of cellular debris in chronic inflammatory and autoimmune disorders. The company was founded by Martin W. Edwards, Konstantinos Efthymiopoulos, David J. Grainger and Christian De La Tour on June 18, 2010 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Other | Founder Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Doctorate Degree | |
| London Business School | College/University | Masters Business Admin Masters Business Admin | |
Stargazer Pharmaceuticals, Inc.
 Stargazer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Stargazer Pharmaceuticals, Inc. manufactures pharmaceutical products. The firm engages in the development of treatment for Stargardt’s disease, a rare form of juvenile, retinal degeneration. The company was founded by Gary Jay Sternberg and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Suomen Itsenäisyyden Juhlarahasto
 Suomen Itsenäisyyden Juhlarahasto Investment ManagersFinance Suomen Itsenäisyyden Juhlarahasto is a Finnish innovation fund directly under the Finnish parliament. It primarily invests in foreign and national funds while making selected follow-up investments in Finnish start-ups and later-stage companies. It can consider investing in foreign companies if it is purposeful for the fund's goals. Its investment focus is in the well-being of the Finnish people, environment, and the economy. The size of its initial venture is up to EUR 2 million and its average investment period per company is from 4 to 10 years. | Investment Managers | Chairman President | |
Ensto Oy
 Ensto Oy Electrical ProductsProducer Manufacturing Ensto Oy designs and provides electrical solutions. Its products include overhead lines, underground networks, network automation, power electronics, installation tools, enclosures, industrial components, lighting equipment, and heating systems. The company offers commercial, industrial, and residential electrification, electricity distribution, electric traffic, and lighting solutions. Ensto was founded by Ensio Miettinen on June 19, 1958 and is headquartered in Porvoo, Finland. | Electrical Products | Director/Board Member Chairman | |
KalVista Pharmaceuticals Ltd.
 KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KalVista Pharmaceuticals Ltd. develops novel plasma kallikrein inhibitors. It also engages in the development of serine protease inhibitors and novel plasma kallikrein inhibitors represent a, approach to the treatment of DME, a leading cause of adult visual loss, plasma kallikrein inhibitors target a distinct molecular pathway and as such have the potential to offer those patients an effective treatment option. The firm has a clinical and advanced pre-clinical product pipeline targeting both intravitreal injection and oral administration, and its plasma kallikrein inhibitors can be applied to additional indications in ophthalmology. The company was founded by Lloyd Paul Aiello, Andrew Crockett, Robert Haigh and Edward P. Feener in 2011 and is headquartered in Porton Down, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| NEXIMMUNE, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chairman | |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
| ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| OBSEVA SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Denemarken | 20 |
| Verenigde Staten | 15 |
| Finland | 12 |
| Verenigd Koninkrijk | 4 |
| Israël | 2 |
Sectoraal
| Health Technology | 28 |
| Consumer Services | 11 |
| Finance | 5 |
| Commercial Services | 4 |
| Producer Manufacturing | 3 |
Operationeel
| Director/Board Member | 682 |
| Corporate Officer/Principal | 206 |
| Chairman | 188 |
| Independent Dir/Board Member | 162 |
| Chief Executive Officer | 84 |
Sterkste connecties
| Insiders | |
|---|---|
| Eivind Kolding | 50 |
| Jack Nielsen | 38 |
| Martin Edwards | 38 |
| Jerome Zeldis | 38 |
| Deepa Pakianathan | 32 |
| Richard H. Aldrich | 31 |
| Carl Goldfischer | 31 |
| Robert Spiegel | 30 |
| Nanna Liebach Lüneborg | 29 |
| Stephan Christgau | 29 |
| Michael Schmertzler | 29 |
| Stig Gustavson | 29 |
| Lars Vinge Frederiksen | 29 |
| Peter Bisgaard | 28 |
| Claus Tycho Bræstrup | 27 |
- Beurs
- Insiders
- Søren Knud Carlsen
- Bedrijfsconnecties
